BSX Q3 2023 Earnings — Boston Scientific Corporation Revenue & Financial Results | Market Cap Arena

BSXBoston Scientific Corporation

$105B

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$3.5B+11.3% YoY

Gross Profit

$2.2B61.4% margin

Operating Income

$558M15.8% margin

Net Income

$504M14.3% margin

EPS (Diluted)

$0.34

QoQ Revenue Growth

-2.0%

Cash Flow

Operating Cash Flow

$698M

Free Cash Flow

$492M

Stock-Based Comp.

$59M

Balance Sheet

Total Assets

$34.0B

Total Liabilities

$14.9B

Stockholders' Equity

$18.9B

Cash & Equivalents

$952M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3.5B	$3.2B	+11.3%
Gross Profit	$2.2B	$1.9B	+12.4%
Operating Income	$558M	$460M	+21.3%
Net Income	$504M	$188M	+168.1%

Revenue Segments

Cardiovascular

$2.2B62%

MedSurg

$1.3B38%

Geographic Segments

UNITED STATES

$2.1B60%

Non-US

$1.4B40%